Inhaled corticosteroids (ICS) have been associated with increased risk of pneumonia. Their
impact on respiratory virus infections is unclear. We performed a post-hoc analysis of the …

Background: Recent studies suggest that the use of inhaled corticosteroids (ICS) may be
associated with a higher risk of pneumonia in patients with COPD. However it is unclear if …

Background. Studies have suggested an increased risk of pneumonia with inhaled
corticosteroid (ICS) use, although this association is inconsistent. We evaluated the risk of …

Background Synthetic glucocorticoids are among the most commonly administered drugs
owing to their potent immunomodulatory properties. However, they may put patients at risk …

Background The use of inhaled corticosteroids (ICSs) is associated with an increased risk of
pneumonia in patients with COPD. However, the risks of other respiratory infections, such as …

Background In clinical trials, the use of inhaled corticosteroids is associated with an
increased risk of pneumonia in people with COPD, but whether the same is true for people …

Background Inhaled corticosteroids (ICS) are associated with an increased risk of clinical
pneumonia among patients with chronic obstructive pulmonary disease (COPD). It is …

Background and objective The impact of inhaled corticosteroid (ICS) use on the
development of pneumonia has been heavily debated. The aim of this study was to …

Background: Inhaled corticosteroids (ICS) are the cornerstone of asthma treatment and
significantly improve morbidity and mortality. Adverse effects of oral corticosteroids are well …

Background Recent studies have suggested a possible association between respiratory
infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper …